Figure 7
Effect of β-cyclodextrin–curcumin on the mount latency, mount frequency, intromission latency, and intromission frequency of hydrocortisone treated male mice. *P < 0.05, **P < 0.01 respect to Model; #P < 0.05, ##P < 0.01 respect to Control. Control normal control group, Model hydrocortisone control group, Positive Jinkui Shenqi Pill group, CDC-L low dose of β-CD-curcumin group, CDC-M medium dose of β-CD-curcumin group, CDC-H high dose of β-CD-curcumin group.
